Lanzul S (Lansoprazole)

Lansoprazole works by irreversibly blocking the H+/K+ ATPase proton pump in gastric parietal cells, the final step in acid secretion. This inhibition prevents hydrogen ions from being released into the stomach, leading to a sustained increase in gastric pH and reduced acidity.

The appropriate dose of Lanzul S is determined by the prescribing healthcare professional based on the specific indication, patient age, renal and hepatic function, and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for lansoprazole in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Lanzul S, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lanzul S (lansoprazole) belongs to the proton pump inhibitor (PPI) class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, lansoprazole has a similar efficacy profile but may differ slightly in metabolism and drug‑interaction potential.

Lanzul S should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Lanzul S is taken orally, usually as a whole tablet swallowed with water. It is generally recommended to take the medication before a meal, but patients should follow the specific timing instructions provided by their prescriber.

Serious risks, though uncommon, include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated diarrhea, and interstitial nephritis. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, persistent watery diarrhea, or unexplained kidney problems.

Lanzul S should be avoided in individuals with known hypersensitivity to lansoprazole or any component of the formulation. Caution is also advised for patients with severe renal or hepatic impairment, and those taking medications that have major interactions, unless a healthcare professional determines that the benefits outweigh the risks.